Nottingham, United Kingdom

Hannah Dexter

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hannah Dexter. Retrieved from https://idiyas.com/inventor/hannah-dexter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Hannah Dexter

Introduction

Hannah Dexter is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific biological pathways.

Latest Patents

Hannah holds 1 patent for her work on Nicotinamide RIPK1 inhibitors. This patent includes compounds of Formula (I) and pharmaceutically acceptable salts that are useful as RIPK1 inhibitors. The patent also details pharmaceutical compositions comprising these compounds and methods for their use and preparation. Additionally, it outlines methods for treating Ulcerative Colitis using a compound of Formula (I).

Career Highlights

Hannah Dexter is currently employed at AbbVie Inc., where she continues to innovate in the pharmaceutical sector. Her work focuses on developing new therapeutic options that can improve patient outcomes.

Collaborations

Throughout her career, Hannah has collaborated with notable colleagues, including Euan Fordyce and Kevin Patrick Cusack. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Hannah Dexter's innovative work in the field of pharmaceuticals, particularly her patent on Nicotinamide RIPK1 inhibitors, showcases her dedication to improving healthcare solutions. Her contributions are significant and reflect her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…